Skip to navigation menu Skip to content
Informational Alert

Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Pediatric Infectious Disease Research Group’s COVID-19 Research

Seattle Children’s Pediatric Infectious Disease Research Group, directed by Dr. Janet Englund, continues to study SARS-CoV-2, the virus causing the disease known as COVID-19.

Most recently, Englund was a co-investigator for the CASCADIA study, which studied how well COVID-19 vaccines protect participants against infection in the community. The study was conducted by the University of Washington School of Medicine and Seattle Children’s Hospital in Seattle and the Kaiser Permanente Center for Health Research in Portland, Oregon, and was funded by the U.S. Centers for Disease Control and Prevention.

COVID-19 Research Studies and Vaccine Clinical Trials

Dr. Englund’s research team may be reached at

Pfizer COVID-19 Booster Study

The Pfizer COVID-19 Booster study will look at how the most recent vaccine booster aims to protect against the COVID-19 illness. Researchers at Seattle Children’s are conducting a COVID-19 vaccine research study for children up to 12 years of age who have never had a COVID-19 vaccine.

Picasso Study

The Picasso study will investigate new methods to protect kids from RSV. Researchers at Seattle Children’s are conducting an RSV vaccine research study for children between the ages of 2 and 17.

Investigating the Virus That Causes COVID-19

Research lead by Dr. Englund and the team have contributed key research to better understand the virus that causes COVID-19 and its effect on the community:

Investigator Biographies